Mitochondrial function among various types of atrial fibrillation: A comparative cross-sectional study

Completed

• Conditions: Patients with Atrial high rate episodes (AHRE)Patient with Atrial Fibrillation (AF)Patient with non AF who have Cardiovascular implantable electronic device (CIED); Mitochondrial dysfunction; Atrial high rate episodes; Atrial Fibrillation; Cardiovascular implantable electronic device

• Registration Number: TCTR20230309004
• Lead Sponsor: The Faculty of Medicine endowment fund for Medical research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-03-09
• Study Completion: 2023-10-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

1. Presence of CIED (pacemaker or defibrillator)
2. Age > 20 years old
3. Given informed consent

Exclusion Criteria

1. Hospitalized, acute coronary syndrome, coronary artery bypass grafting, percutaneous coronary intervention, or cardioversion within 3 months
2. Atrial arrhythmia ablation within previous 3 months or currently plan
3. Primary electrical disease (e.g. Idiopathic ventricular fibrillation, long QT syndrome, Bragada syndrome)

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mitochondrial function 1 day Mitochondrial function test

Secondary Outcome Measures

Name	Time	Method
Inflammatory process 1 day Inflammatory test,Oxidative stress 1 day Oxidative stress test